Skip to content

Role of Platelet and granule contents in hepatocellular carcinoma

Role of Platelet and granule contents in hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037781
Enrollment
Unknown
Registered
2020-09-01
Start date
2020-09-15
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

High level of platelet (content) group:No
Low level of platelet (content) group :No

Sponsors

The First Affiliated Hospital of Bengbu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years old; 2. Patients with hepatocellular carcinoma caused by chronic hepatitis B (HBsAg positive); 3. received radical partial hepatectomy for the first time.

Exclusion criteria

Exclusion criteria: 1. Hepatocellular carcinoma caused by other etiologies, such as HCV, or patients with HIV infection; 2. Planning to receive other surgical treatment, such as RFA, TACE, liver transplantation, etc.; 3. Surgical history for hepatocellular carcinoma; 4. Accompanied by tumors in other sites; 5. Hematological diseases, recent use of antiplatelet drugs and other factors that significantly affect platelets or contents.

Design outcomes

Primary

MeasureTime frame
Postoperative liver regeneration;Overall survival;Distant metastasis;

Secondary

MeasureTime frame
Postoperative complications;Postoperative complications;Disease free survival;Intrahepatic metastasis;

Countries

China

Contacts

Public ContactPang Qing

The First Affiliated Hospital of Bengbu Medical College of Anhui Province

portxiu2@126.com+86 15755275507

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026